18FFDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab

URN:NBN:SI:doc-IURS5TXU2020Ahac, ValentinaBoc, NinaEickhoff, Jens C.Jeraj, RobertSimončič, UrbanStuden, AndrejŠkalič, KatjaUnk, MojcaValentinuzzi, DamijanVrankar, MartinaZupančič, ŽigaŽagar, Ivanadocuments/doc/I/URN_NBN_SI_doc-IURS5TXU_001.pdfdocuments/doc/I/URN_NBN_SI_doc-IURS5TXU_001.txt354articlestr. 285-294, IV10.2478/raon-2020-00421318-209924723203URN:NBN:SI:doc-IURS5TXUengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYmedicinska fizikapljučarak (medicina)tumorski označevalcizdravljenje18FFDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab